Metformin in High Metabolic Risk Pregnancies - A Patient-Level Meta-Analysis.
In this IPD meta-analysis, metformin was not associated with a reduction in GDM, but was associated with an increase in gestational age at delivery, and Gastrointestinal side effects were more commonly reported with metformin.